Committed to excellence in patient care, research and education, Loma Linda University Medical Center & Children’s Hospital (LLUMC&CH) Transplantation Institute physicians conduct leading research and write scholarly articles. These publications educate patients and caregivers and expand our healthcare professionals’ knowledge in the field of transplantation. Here's a list of some publications, papers and abstracts written by LLUMC Transplantation Institute physicians:

• A therapeutic DNA vaccination strategy for autoimmunity and transplantation. Li A, Chen J, Hattori M, Franco E, Zuppan C, Ojogho O, Iwaki Y, Escher A. Vaccine. 2010 Feb 23; 28(8):1897-904.
• Bioluminescent mammalian cells grown in sponge matrices to monitor immune rejection. Ojogho O, Li A, Zuppan CW, Escher A. Mol Imaging. 2007 Sep-Oct; 6(5):323-30.
• Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro. Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.Vaccine. 2006 Jun 5; 24(23):5036-46. Epub 2006 Mar 31. Erratum in: Vaccine. 2007 Jan 4; 25(2):399.
• Saving death: apoptosis for intervention in transplantation and autoimmunity. Li A, Ojogho O, Escher A. Clin Dev Immunol. 2006 Jun-Dec; 13(2-4):273-82.
• Neurodevelopmental outcome of solid organ transplantation in children. Baum M, Freier MC, Chinnock RE. Pediatr Clin North Am. 2003 Dec; 50(6):1493-503, x. Review.

Heart

• Pericardial constriction after cardiac transplantation. Bansal R, Perez L, Razzouk A, Wang N, Bailey L. J Heart Lung Transplant. 2010 Mar; 29(3):371-7. Epub 2009 Oct 4.
• The evolution of infant heart transplantation. Bailey LL. J Heart Lung Transplant. 2009 Dec; 28(12):1241-5. Epub 2009 Oct 8. No abstract available.
• Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms. Girnita DM, Webber SA, Brooks MM, Ferrell R, Girnita AL, Burckart GJ, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel D, Zeevi A. Transplantation. 2009 Jun 27; 87(12):1801-6.
• Courage and character, leaders and legends: an interview with Leonard Bailey, MD. Interview by Linda Ohler. Bailey L. Prog Transplant. 2009 Jun; 19(2):108-10. No abstract available.
• Pediatric transplantation using hearts refused on the basis of donor quality. Bailey LL, Razzouk AJ, Hasaniya NW, Chinnock RE. Ann Thorac Surg. 2009 Jun; 87(6):1902-8; discussion 1908-9.
• Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort. Zuppan CW, Wells LM, Kerstetter JC, Johnston JK, Bailey LL, Chinnock RE. J Heart Lung Transplant. 2009 Jun; 28(6):579-84. Epub 2009 May 5.
• Developmental outcomes after pediatric heart transplantation. Chinnock RE, Freier MC, Ashwal S, Pivonka-Jones J, Shankel T, Cutler D, Bailey L. J Heart Lung Transplant. 2008 Oct; 27(10):1079-84.
• Late outcomes of pediatric heart transplantation are independent of pre-transplant diagnosis and prior cardiac surgical intervention. Dionigi B, Razzouk AJ, Hasaniya NW, Chinnock RE, Bailey LL. J Heart Lung Transplant. 2008 Oct; 27(10):1090-5.
• Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Girnita DM, Brooks MM, Webber SA, Burckart GJ, Ferrell R, Zdanowicz G, DeCroo S, Smith L, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Ranganathan S, Naftel D, Girnita AL, Zeevi A. Transplantation. 2008 Jun 15; 85(11):1632-9.
• Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Rood PP, Tai HC, Hara H, Long C, Ezzelarab M, Lin YJ, van der Windt DJ, Busch J, Ayares D, Ijzermans JN, Wolf RF, Manji R, Bailey L, Cooper DK. Transpl Int. 2007 Dec;20(12):1050-8. Epub 2007 Sep 10.
• Decreased exercise performance with age in children with hypoplastic left heart syndrome. Jenkins PC, Chinnock RE, Jenkins KJ, Mahle WT, Mulla N, Sharkey AM, Flanagan MF. J Pediatr. 2008 Apr; 152(4):507-12. Epub 2007 Nov 19.
• Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Girnita DM, Webber SA, Ferrell R, Burckart GJ, Brooks MM, McDade KK, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Girnita AL, Zeevi A. Transplantation. 2006 Dec 27; 82(12):1774-80.
• Management of infants and young children with combined heart and kidney failure. Sahney S, Chinnock R. Pediatr Transplant. 2006 Jun; 10(4):408-12. Review.
• Lessons learned from the pediatric heart transplant study. Hsu DT, Naftel DC, Webber SA, Morrow WR, Canter CE, Chinnock RE, Clark ML, Kirklin JK. Congenit Heart Dis. 2006 May; 1(3):54-62.
• Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Mahle WT, Visconti KJ, Freier MC, Kanne SM, Hamilton WG, Sharkey AM, Chinnock RE, Jenkins KJ, Isquith PK, Burns TG, Jenkins PC. Pediatrics. 2006 Jan; 117(1):e90-7. Epub 2005 Dec 15.
• The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. Pahl E, Naftel DC, Kuhn MA, Shaddy RE, Morrow WR, Canter CE, Kirklin J; Pediatric Heart Transplant Study. J Heart Lung Transplant. 2005 Jun; 24(6):645-51.
• Transplantation is the best treatment for hypoplastic left heart syndrome. Bailey LL. Cardiol Young. 2004 Feb;14 Suppl 1:109-11; discussion 112-4. No abstract available.
• Scoring system to determine need for balloon atrial septostomy for restrictive interatrial communication in infants with hypoplastic left heart syndrome. Mulla NF, Osher AP, Beeson WL, Kuhn MA, Larsen RL. J Heart Lung Transplant. 2003 Aug; 22(8):883-8.
• Post-transplant seizures in infants with hypoplastic left heart syndrome. Raja R, Johnston JK, Fitts JA, Bailey LL, Chinnock RE, Ashwal S. Pediatr Neurol. 2003 May; 28(5):370-8.
• Moderate acute rejection detected during annual catheterization in pediatric heart transplant recipients. Kuhn MA, Deming DD, Cephus CE, Mulla NF, Chinnock RE, Razzouk AJ, Larsen RL. J Heart Lung Transplant. 2003 Mar; 22(3):276-80.
• Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients. Hathout EH, Chinnock RE, Johnston JK, Fitts JA, Razzouk AJ, Mace JW, Bailey LL. Am J Transplant. 2003 Aug; 3(8):994-8.
• Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen. Asano M, Gundry SR, Izutani H, Cannarella SN, Fagoaga O, Bailey LL. J Thorac Cardiovasc Surg. 2003 Jan;125(1):60-69; discussion 69-70.
• Total lymphoid irradiation for refractory rejection in pediatric heart transplantation. Asano M, Gundry SR, Razzouk AJ, del Rio MJ, Thomas M, Chinnock RE, Bailey LL; Pediatric Heart Transplantation Group. Ann Thorac Surg. 2002 Dec; 74(6):1979-85.
• Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Scheule AM, Zimmerman GJ, Johnston JK, Razzouk AJ, Gundry SR, Bailey LL. Circulation. 2002 Sep 24; 106(12 Suppl 1):I163-7.
• Usefulness of cardiac transplantation in children with visceral heterotaxy (asplenic and polysplenic syndromes and single right-sided spleen with levocardia) and comparison of results with cardiac transplantation in children with dilated cardiomyopathy. Larsen RL, Eguchi JH, Mulla NF, Johnston JK, Fitts J, Kuhn MA, Razzouk AJ, Chinnock RE, Bailey LL. Am J Cardiol. 2002 Jun 1; 89(11):1275-9.
• Cholelithiasis in infant and pediatric heart transplant patients. Sakopoulos AG, Gundry S, Razzouk AJ, Andrews HG, Bailey LL. Pediatr Transplant. 2002 Jun; 6(3):231-4.

Kidney

• The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients. Ben-Youssef R, Baron PW, Sahney S, Weissman J, Baqai W, Franco E, Kore A, Trimzi M, Ojogho O. Pediatr Transplant. 2008 Oct 31.
• Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective study. Baron PW, Ojogho ON, Yorgin P, Sahney S, Cutler D, Ben-Youssef R, Baqai W, Weissman J, Franco E, Zuppan C, Concepcion W. Pediatr Transplant. 2008 Feb;12(1):32-9.
• Increased creatine kinase and its effect on kidney function in hand assisted laparoscopic kidney donors and their recipients. Harper JD, Baron PW, Ojogho ON, Baldwin DD. J Urol. 2007 Oct; 178(4 Pt 1):1391-5; discussion 1395.
• Simultaneous pediatric kidney transplantation and ureterocystoplasty in a 20-month-old boy. Ojogho ON, Ben-Youssef R, Chen LJ, Baron PW, Franco ES, Baldwin DD. Pediatr Transplant. 2007 Jun; 11(4):436-40.
• Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection. Baron PW, Majlessipour F, Bedros AA, Zuppan CW, Ben-Youssef R, Yanni G, Ojogho ON, Concepcion W. Pediatr Transplant. 2007 Jun; 11(4):436-40.
• Successful living related kidney transplantation across an anti-donor HLA antibody. Ben-Youssef R, Iwaki Y, Baron P, Franco E, Rowsell E, Buckert L, Ojogho O. Transplant Proc. 2006 Jun;38(5):1280-2.
• Control of the renal artery and vein with the nonabsorbable polymer ligating clip in hand-assisted laparoscopic donor nephrectomy. Baldwin DD, Desai PJ, Baron PW, Berger KA, Maynes LJ, Robson CH, Ojogho ON, Concepcion W. Transplantation. 2005 Aug 15; 80(3):310-3.
• Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab. Ojogho O, Sahney S, Cutler D, Baron PW, Abdelhalim FM, James S, Zuppan C, Franco E, Concepcion W. Pediatr Transplant. 2005 Feb; 9(1):80-3.
• Hand-assisted laparoscopic donor nephrectomy is safe and results in increased kidney donation. Baron PW, Baldwin DD, Hadley HR, Ojogho ON, Ruckle HC, Concepcion W. Am Surg. 2004 Oct;70(10):901-5.
• Use of basiliximab with mycophenolate mofetil in kidney transplantation. Baron PW, Weissman J, Ojogho ON, Sahney S, Cutler D, James S, Oculam C, Abdelhalim F, Nehlsen-Cannarella SL, Teichman S, Concepcion W. Transplant Proc. 2003 Dec;35(8):2881-4.
• Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation. Ojogho O, Sahney S, Cutler D, Baron PW, Abdelhalim FM, Hasan SM, Concepcion W. Pediatr Transplant. 2003 Apr; 7(2):137-41.
• Mycophenolate mofetil without antibody induction in pediatric renal transplantation. Ojogho ON, Sahney S, Cutler D, Baron PW, Abdelhalim FM, Hasan SM, Concepcion W. Transplant Proc. 2002 Aug;34(5):1953-4.
• Superior long-term results of renal transplantation in children under 5 years of age. Ojogho O, Sahney S, Cutler D, Abdelhalim F, Hasan M, Baron P, Concepcion W. Am Surg. 2002 Dec;68(12):1115-9.

Pancreas

• Intrapyloric injection of botulinum toxin for the treatment of persistent gastroparesis following successful pancreas transplantation. Ben-Youssef R, Baron PW, Franco E, Walter MH, Lewis T, Ojogho O. Am J Transplant. 2006 Jan; 6(1):214-8.
• Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Burke GW 3rd, Kaufman DB, Millis JM, Gaber AO, Johnson CP, Sutherland DE, Punch JD, Kahan BD, Schweitzer E, Langnas A, Perkins J, Scandling J, Concepcion W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Danovitch G, Henning AK, Bartucci MR, Smith S, Fitzsimmons WE. Transplantation. 2004 Apr 27; 77(8):1269-75.
• Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Kaufman DB, Iii GW, Bruce DS, Johnson CP, Gaber AO, Sutherland DE, Merion RM, Gruber SA, Schweitzer E, Leone JP, Marsh CL, Alfrey E, Concepcion W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Smith C, Henning AK, Kuehnel F, King S, Fitzsimmons WE. Am J Transplant. 2003 Jul; 3(7):855-64.

Liver

• Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Liver Transpl. 2008 Sep; 14(9):1313-22.
• Hemobilia secondary to a posttransplant lymphoma after liver transplantation. Baron P, Ben-Youssef R, Ojogho O, Franco E, Concepcion W, Smith D. Transplantation. 2005 Jun 27; 79(12):1766-7.
• Successful liver transplantation using a HELLP syndrome donor. Baron PW, Ojogho ON, Chick W, Concepcion W. Transplantation. 2004 Sep 15; 78(5):782-3.
• Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W. Am J Dermatopathol. 2003 Jun; 25(3):204-9.
• Small-diameter portacaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function. Hillebrand DJ, Kojouri K, Cao S, Runyon BA, Ojogho O, Concepcion W. Liver Transpl. 2000 Jul; 6(4):459-65.

Hepatology / Liver Disease

• Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction. Kayali Z, Herring J, Baron P, Franco E, Ojogho O, Smith J, Watkins G, Smith D, Lamin V, Hoang T, Sharma R, Mathahs M, Sowers L, Brown KE, Schmidt WN. J Gastroenterol Hepatol. 2009 Jun; 24(6):1030-7.
• Concomitant hepatic encephalopathy and refractory ascites: successful treatment with staged embolization of two large portosystemic shunts and transjugular intrahepatic portosystemic shunt placement. Smith JC, Black MD, Mendler MH. J Vasc Interv Radiol. 2007 Nov; 18(11):1441-6.

Contact Us

With the accessibility of our facilities and ease of scheduling an appointment, LLUMC’s compassionate staff is dedicated to providing you with whole-person care. Our commitment to the well-being of your mind, body and spirit begins with your request for an appointment. Make an appointment by calling us toll-free at 1-800-548-3790 or locally at 909-558-3636, by filling out the online request form or by visiting our facilities today